Took Carbonman's advice and doubled holding at 5.9c.Been in this stock for a long time already and prepared to wait for at least another year to see its value realised.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%